Click for best price
Dengue Vaccines Market Size, Share 2023
| Market size in 2022 |
US$ 412.2 million
|
Forecast Market size by 2029 |
US$ 1010.9 million
|
| Growth Rate |
CAGR of 13.7% |
Number of Pages |
68 Pages |
Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.
This report aims to provide a comprehensive presentation of the global market for Dengue Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dengue Vaccines. This report contains market size and forecasts of Dengue Vaccines in global, including the following market information:
Global Dengue Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Dengue Vaccines market was valued at US$ 412.2 million in 2022 and is projected to reach US$ 1010.9 million by 2029, at a CAGR of 13.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.
We surveyed the Dengue Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dengue Vaccines Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Dengue Vaccines Market Segment Percentages, by Type, 2022 (%)
Dengvaxia
TAK-003
Others
Global Dengue Vaccines Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Dengue Vaccines Market Segment Percentages, by Application, 2022 (%)
Public Sector
Private Sector
Global Dengue Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Dengue Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dengue Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Dengue Vaccines revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dengue Vaccines, market overview.
Chapter 2: Global Dengue Vaccines market size in revenue.
Chapter 3: Detailed analysis of Dengue Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dengue Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Dengue Vaccines Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 412.2 million
|
| Forecast Market size by 2029 |
US$ 1010.9 million
|
| Growth Rate |
CAGR of 13.7% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Dengue Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dengue Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dengue Vaccines Overall Market Size
2.1 Global Dengue Vaccines Market Size: 2022 VS 2029
2.2 Global Dengue Vaccines Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Dengue Vaccines Players in Global Market
3.2 Top Global Dengue Vaccines Companies Ranked by Revenue
3.3 Global Dengue Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Dengue Vaccines Companies in Global Market, by Revenue in 2022
3.5 Global Companies Dengue Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dengue Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Dengue Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Dengue Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Dengue Vaccines Market Size Markets, 2022 & 2029
4.1.2 Dengvaxia
4.1.3 TAK-003
4.1.4 Others
4.2 By Type - Global Dengue Vaccines Revenue & Forecasts
4.2.1 By Type - Global Dengue Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Dengue Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Dengue Vaccines Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dengue Vaccines Market Size, 2022 & 2029
5.1.2 Public Sector
5.1.3 Private Sector
5.2 By Application - Global Dengue Vaccines Revenue & Forecasts
5.2.1 By Application - Global Dengue Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Dengue Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Dengue Vaccines Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Dengue Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Dengue Vaccines Revenue & Forecasts
6.2.1 By Region - Global Dengue Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Dengue Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Dengue Vaccines Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Dengue Vaccines Revenue, 2018-2029
6.3.2 US Dengue Vaccines Market Size, 2018-2029
6.3.3 Canada Dengue Vaccines Market Size, 2018-2029
6.3.4 Mexico Dengue Vaccines Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Dengue Vaccines Revenue, 2018-2029
6.4.2 Germany Dengue Vaccines Market Size, 2018-2029
6.4.3 France Dengue Vaccines Market Size, 2018-2029
6.4.4 U.K. Dengue Vaccines Market Size, 2018-2029
6.4.5 Italy Dengue Vaccines Market Size, 2018-2029
6.4.6 Russia Dengue Vaccines Market Size, 2018-2029
6.4.7 Nordic Countries Dengue Vaccines Market Size, 2018-2029
6.4.8 Benelux Dengue Vaccines Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Dengue Vaccines Revenue, 2018-2029
6.5.2 China Dengue Vaccines Market Size, 2018-2029
6.5.3 Japan Dengue Vaccines Market Size, 2018-2029
6.5.4 South Korea Dengue Vaccines Market Size, 2018-2029
6.5.5 Southeast Asia Dengue Vaccines Market Size, 2018-2029
6.5.6 India Dengue Vaccines Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Dengue Vaccines Revenue, 2018-2029
6.6.2 Brazil Dengue Vaccines Market Size, 2018-2029
6.6.3 Argentina Dengue Vaccines Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Dengue Vaccines Revenue, 2018-2029
6.7.2 Turkey Dengue Vaccines Market Size, 2018-2029
6.7.3 Israel Dengue Vaccines Market Size, 2018-2029
6.7.4 Saudi Arabia Dengue Vaccines Market Size, 2018-2029
6.7.5 UAE Dengue Vaccines Market Size, 2018-2029
7 Dengue Vaccines Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Dengue Vaccines Major Product Offerings
7.1.4 Sanofi Dengue Vaccines Revenue in Global Market (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Takeda
7.2.1 Takeda Company Summary
7.2.2 Takeda Business Overview
7.2.3 Takeda Dengue Vaccines Major Product Offerings
7.2.4 Takeda Dengue Vaccines Revenue in Global Market (2018-2023)
7.2.5 Takeda Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Dengue Vaccines Market Opportunities & Trends in Global Market
Table 2. Dengue Vaccines Market Drivers in Global Market
Table 3. Dengue Vaccines Market Restraints in Global Market
Table 4. Key Players of Dengue Vaccines in Global Market
Table 5. Top Dengue Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Dengue Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Dengue Vaccines Revenue Share by Companies, 2018-2023
Table 8. Global Companies Dengue Vaccines Product Type
Table 9. List of Global Tier 1 Dengue Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dengue Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Dengue Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Dengue Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Dengue Vaccines Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Dengue Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Dengue Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Dengue Vaccines Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Dengue Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Dengue Vaccines Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Dengue Vaccines Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Dengue Vaccines Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Dengue Vaccines Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Dengue Vaccines Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Dengue Vaccines Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Dengue Vaccines Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Dengue Vaccines Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Dengue Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Dengue Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Dengue Vaccines Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Dengue Vaccines Revenue, (US$, Mn), 2024-2029
Table 30. Sanofi Company Summary
Table 31. Sanofi Dengue Vaccines Product Offerings
Table 32. Sanofi Dengue Vaccines Revenue (US$, Mn) & (2018-2023)
Table 33. Sanofi Key News & Latest Developments
Table 34. Takeda Company Summary
Table 35. Takeda Dengue Vaccines Product Offerings
Table 36. Takeda Dengue Vaccines Revenue (US$, Mn) & (2018-2023)
Table 37. Takeda Key News & Latest Developments
List of Figures
Figure 1. Dengue Vaccines Segment by Type in 2022
Figure 2. Dengue Vaccines Segment by Application in 2022
Figure 3. Global Dengue Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Dengue Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Dengue Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dengue Vaccines Revenue in 2022
Figure 8. By Type - Global Dengue Vaccines Revenue Market Share, 2018-2029
Figure 9. By Application - Global Dengue Vaccines Revenue Market Share, 2018-2029
Figure 10. By Type - Global Dengue Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Dengue Vaccines Revenue Market Share, 2018-2029
Figure 12. By Application - Global Dengue Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Dengue Vaccines Revenue Market Share, 2018-2029
Figure 14. By Region - Global Dengue Vaccines Revenue Market Share, 2018-2029
Figure 15. By Country - North America Dengue Vaccines Revenue Market Share, 2018-2029
Figure 16. US Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Dengue Vaccines Revenue Market Share, 2018-2029
Figure 20. Germany Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 21. France Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Dengue Vaccines Revenue Market Share, 2018-2029
Figure 28. China Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. India Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Dengue Vaccines Revenue Market Share, 2018-2029
Figure 34. Brazil Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Dengue Vaccines Revenue Market Share, 2018-2029
Figure 37. Turkey Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Dengue Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. Sanofi Dengue Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Takeda Dengue Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
